NCT03910751 - POLESTAR Trial - An International Multi-center Early Discharge TAVI Program | Biotech Hunter

Enrollment

252

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

December 5, 2022

Study Completion Date

January 24, 2024

Conditions

Aortic Valve Stenosis

Interventions

DEVICE

Transcatheter Aortic Valve Implantation with ACURATE Neo Aortic Bioprosthesis

Transfemoral TAVI using the Boston Scientific ACURATE Neo Aortic Bioprosthesis

Trial Locations (15)

ASZ Aalst, Aalst

AZ Sint-Jan Brugge, Bruges

UZ Brussel, Brussels

AZ Maria Middelares, Ghent

Royal Columbian Hospital, New Westminster

Sunnybrook Health Sciences Centre, Toronto

Vancouver General Hospital, Vancouver

University Medical Center Groningen, Groningen

Leiden University Medical Center, Leiden

St. Antonius Hospital, Nieuwegein

Utrecht University Medical Center, Utrecht

University Hospital Sussex NHS Foundation Trust, Brighton

Leeds Teaching Hospitals NHS Trust, Leeds

University Hospitals of Leicester NHS Trust, Leicester

Erasmus University Medical Center, Rotterdam